Ignite Creation Date:
2025-12-26 @ 11:47 AM
Ignite Modification Date:
2026-05-29 @ 12:42 PM
Study NCT ID:
NCT05758116
Status:
RECRUITING
Last Update Posted:
2024-11-26
First Post:
2023-02-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tislelizumab Consolidation Therapy After Radiotherapy or Sequential Chemoradiation in Locally Advanced NSCLC Patients
Sponsor:
Peking University Cancer Hospital & Institute
Organization: